|

LP-003 Injection Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Longbio Pharma1

Indications

  • Allergic Asthma1
  • Asthma1

Other1 trial

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.